FDA revokes authorization for treatment with COVID-19 antibodies bamlanivimab
The Food and Drug Administration (FDA) has withdrawn its emergency use authorization for the monoclonal antibody bamlanivimab to be used alone as a treatment against COVID-19 due to resistance to t…
